Additionally, transgenic mice engineered to overexpress human resistin displayed significant cardiac hypertrophy, fibrosis, and diastolic dysfunction, reinforcing the hormone’s role in adverse cardiac remodeling [94,95]. The gene discussed is RETN; the disease is cardiac hypertrophy.